Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

U.S. stocks gain as market looks past GDP data; Dow gains 0.29%

Published 06/25/2014, 04:39 PM
Updated 06/25/2014, 04:42 PM
Stocks shrug off GDP report and rise on hopes for more upbeat second quarter

Investing.com - U.S. stocks rose on Wednesday after investors took a dismal first-quarter GDP report in stride, betting that the second quarter will reveal a solid uptick in economic activity.

At the close of U.S. trading, the Dow 30 rose 0.29%, the S&P 500 index rose 0.49%, while the NASDAQ Composite index rose 0.68%.

The Volatility S&P 500 index, which measures the outlook for market volatility, was down 4.45% at 11.59.

The Commerce Department reported earlier that U.S. gross domestic product contracted at an annual rate of 2.9% in the first quarter of the year, far surpassing consensus forecasts for a decline of 1.7%.

U.S. first-quarter GDP was initially reported to have increased by 0.1%, but was subsequently revised to show a contraction of 1.0%.

The difference between the second and third estimate was the largest since records began in 1976, the Commerce Department added.

A separate report showed that U.S. durable goods orders fell 1.0% in May, while core durable goods orders fell 0.1%. Market expectations had been for an increase of 0.2% and 0.4%, respectively.

Stocks rose anyway, as recent housing and other economic indicators have depicted a U.S. economy that is rebounding from a rough winter that seriously disrupted commerce.

First-quarter earnings have given investors room to believe that the economy is gaining steam as well.

Meanwhile in corporate news, drug maker Bristol-Myers Squibb Company (NYSE:BMY) saw its shares rise earlier on news of positive results of an experimental skin-cancer drug's trial.

Cereal maker General Mills Inc (NYSE:GIS) shares fell on disappointing earnings, while agribusiness giant Monsanto Company (NYSE:MON) hiked its earnings outlook for the year.

In other news, the Supreme Court ruled in favor of television broadcasters on their assertions that TV startup Aereo had violated copyright law.

Leading Dow Jones Industrial Average performers included Nike Inc (NYSE:NKE), up 1.97%, Pfizer Inc (NYSE:PFE), up 1.69%, and Merck & Company Inc (NYSE:MRK), up 1.60%.

The Dow Jones Industrial Average's worst performers included Boeing Company (NYSE:BA), down 1.63%, General Electric Company (NYSE:GE), down 0.58%, and Exxon Mobil Corporation (NYSE:XOM), down 0.56%.

European indices, meanwhile, ended the day lower.

After the close of European trade, the DJ Euro Stoxx 50 fell 0.85%, France's CAC 40 fell 1.28%, while Germany's DAX fell 0.71%. Meanwhile, in the U.K. the FTSE 100 fell 0.79%.

On Thursday, the U.S. is to release data on personal income and expenditure, as well as data on inflation linked to personal spending.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.